American Medical Systems Acquires Solarant Medical

Minnetonka, MN-based American Medical Systems, Inc. announced its acquisition of Solarant Medical, Inc., a privately funded company focused on the development of minimally invasive therapies for women who suffer from stress urinary incontinence. The purchase price is comprised of an initial payment and the potential for future payments linked to certain key milestones including FDA approval of the therapy and the establishment of reimbursement codes applicable to both the hospital and office settings. The former Solarant shareholders would also receive an earnout based on revenues achieved during the first three years in the event of product commercialization. In addition to these acquisition payments, AMS previously funded $1.0 million of Solarant’s development efforts. Specific details of this acquisition will be filed with the SEC on Form 8K.
    “Officebased incontinence therapy will be the means by which physicians will ultimately reach a significantly greater number of the 80 million women around the world suffering from stress incontinence,” said Martin J. Emerson, president and CEO of American Medical Systems. “We at AMS are eager to actively advance the development activities to this end based upon the solid foundation of the Solarant intellectual property portfolio and product concepts.”
    American Medical Systems is a diversified supplier of medical devices and procedures to cure erectile dysfunction, benign prostatic hyperplasia, incontinence, menorrhagia, prolapse and other pelvic disorders in men and women.